De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Dolby Laboratories Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Dolby Laboratories heeft een totaal eigen vermogen van $2.4B en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $3.0B en $526.2M. De EBIT Dolby Laboratories is $246.7M waardoor de rentedekking -6.8 is. Het heeft contanten en kortetermijnbeleggingen van $869.0M.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
| Rente dekkingsratio | -6.8x |
| Contant | US$868.96m |
| Aandelen | US$2.45b |
| Totaal verplichtingen | US$526.20m |
| Totaal activa | US$2.97b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Sep 22
Dolby Laboratories: Need To See Improvements In Sales Before Committing Capital
Aug 22Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion
Aug 13We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)
Jul 26Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation
Jun 10Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?
Jun 07Dolby Laboratories Remains A Hold
May 14Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 05Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors
May 02Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist
Apr 16Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate
Mar 17Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)
Mar 01Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye
Feb 09What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jan 31With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For
Jan 15The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising
Dec 28Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue
Dec 06A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Nov 18At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?
Oct 11Dolby Laboratories: High P/E Is Not Justified, A Hold For Now
Sep 13The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
Aug 03What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jul 12Dolby Laboratories Sees Return To Growth Ahead
Jun 22Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture
May 04A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Apr 14Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Mar 29Dolby Laboratories goes ex-dividend on Monday
Feb 10Dolby Laboratories FQ1 2023 Earnings Preview
Feb 01Dolby Laboratories (NYSE:DLB) Could Be At Risk Of Shrinking As A Company
Jan 24Dolby: A 2023 Update, And Still A 'Hold'
Jan 11An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 25% Undervalued
Jan 09Is Dolby Laboratories, Inc. (NYSE:DLB) Potentially Undervalued?
Dec 25Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $1.5B ) DLB } overtreffen de korte termijn passiva ( $354.5M ).
Langlopende schulden: De kortetermijnactiva DLB ( $1.5B ) overtreffen de langetermijnschulden ( $171.7M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: DLB is schuldenvrij.
Schuld verminderen: DLB heeft de afgelopen 5 jaar geen schulden gehad.
Schuldendekking: DLB heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.
Rentedekking: DLB heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.